Literature DB >> 26763852

Biomarkers of lipid peroxidation related to hypertension in aging.

Hakan Yavuzer1, Serap Yavuzer2, Mahir Cengiz2, Hayriye Erman3, Alper Doventas1, Huriye Balci4, Deniz Suna Erdincler1, Hafize Uzun5.   

Abstract

The aim of this clinical study was to evaluate the influence of aging on the levels of lipid peroxidation (quantified as thiobarbituric acid-reactive substances (TBARS) content), lipid hydroperoxide (LOOH), hexanoyl lysine (HEL), 8-iso-prostaglandin F2α (8-iso-PGF2α) and total antioxidant capacity (TAC), and determine their relationships to the demographic and cardiovascular risk factors in elderly hypertensive (HT) patients. This study consisted of four groups: two elderly groups with 30 HT patients (11 males, 19 females) and 30 normotensive healthy volunteers (15 males, 15 females), and two young groups with 30 HT patients (13 males, 17 females) and 30 normotensive healthy volunteers (12 males, 18 females). In the elderly control group, the TBARS, LOOH, HEL and 8-iso-PGF2α levels, and the carotid intima media thickness (CIMT) were significantly higher than in the young control group. The TBARS, LOOH, HEL and 8-iso-PGF2α levels and the CIMT measurements were significantly higher in the elderly HT group than in the young HT group. In addition, the TAC levels were significantly lower in the elderly and young HT groups than in the elderly and young control groups. The CIMT was significantly positively correlated with TBARS (r=0.40, P<0.001), HEL (r= 0.30, P=0.001), LOOH (r= 0.44, P<0.001) and 8-iso-PGF2α (r= 0.32, P<0.001) in all of the HT groups. It seems that in elderly patients, the LOOH and TBARS are better biomarkers of lipid peroxidation in hypertension in terms of sensitivity. In all of the HT groups, 8-iso-PGF2α had the highest sensitivity. Hypertension is associated with lipid peroxidation due to an impaired oxidant/antioxidant status. Increased lipid peroxidation and decreased antioxidants with aging indicate that peroxidative damage further increases with higher blood pressure and the aging process.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763852     DOI: 10.1038/hr.2015.156

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  37 in total

1.  Study of factors influencing the decreased HDL associated PON1 activity with aging.

Authors:  Ildiko Seres; Gyorgy Paragh; Elaine Deschene; Tamas Fulop; Abdelouahed Khalil
Journal:  Exp Gerontol       Date:  2004-01       Impact factor: 4.032

2.  Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension.

Authors:  Ana Paula Cabral de Faria; Vanessa Fontana; Rodrigo Modolo; Natália Ruggeri Barbaro; Andréa Rodrigues Sabbatini; Isabella Fagian Pansani; Silvia E Ferreira-Melo; Heitor Moreno
Journal:  Clin Chim Acta       Date:  2014-03-19       Impact factor: 3.786

3.  Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats.

Authors:  Sae Mi Yoo; Sung Hyun Choi; Monica Dha Yea Jung; Sung Cil Lim; Sang Hong Baek
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

Review 4.  Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.

Authors:  Samar Basu
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-04-02       Impact factor: 4.006

5.  Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project.

Authors:  Atsushi Hozawa; Satoru Ebihara; Kaori Ohmori; Shinichi Kuriyama; Takashi Ugajin; Yayoi Koizumi; Yoshinori Suzuki; Toshifumi Matsui; Hiroyuki Arai; Yoshitaka Tsubono; Hidetada Sasaki; Ichiro Tsuji
Journal:  Hypertens Res       Date:  2004-08       Impact factor: 3.872

6.  Oxidative stress and aging: correlation with clinical parameters.

Authors:  Ana Carla da Cruz; Fabricia Petronilho; Claudia Cipriano Vidal Heluany; Francieli Vuolo; Samantha Pereira Miguel; João Quevedo; Marco Aurélio Romano-Silva; Felipe Dal-Pizzol
Journal:  Aging Clin Exp Res       Date:  2013-12-03       Impact factor: 3.636

7.  Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease.

Authors:  Yildiz Dincer; Nigar Sekercioglu; Meltem Pekpak; Kezban N Gunes; Tulay Akcay
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

8.  Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.

Authors:  Norihisa Ito; Mitsuru Ohishi; Koichi Yamamoto; Yuji Tatara; Atsushi Shiota; Norihiro Hayashi; Norio Komai; Yoshihiro Yanagitani; Hiromi Rakugi; Toshio Ogihara
Journal:  Am J Hypertens       Date:  2007-07       Impact factor: 2.689

Review 9.  Determination of HEL (Hexanoyl-lysine adduct): a novel biomarker for omega-6 PUFA oxidation.

Authors:  Kazuo Sakai; Satoko Kino; Aino Masuda; Masao Takeuchi; Tairin Ochi; Josko Osredkar; Barbara Rejc; Ksenija Gersak; Narasimhan Ramarathnam; Yoji Kato
Journal:  Subcell Biochem       Date:  2014

10.  Oxidative stress in white coat hypertension; role of paraoxonase.

Authors:  H Uzun; Y Karter; S Aydin; A Curgunlu; G Simşek; R Yücel; S Vehiyd; N Ertürk; A Kutlu; A Benian; A Yaldiran; E Oztürk; S Erdine
Journal:  J Hum Hypertens       Date:  2004-07       Impact factor: 3.012

View more
  14 in total

1.  Mechanistic Biomarkers in Toxicology

Authors:  Sonia Sanajou; Gönül Şahin
Journal:  Turk J Pharm Sci       Date:  2021-06-18

Review 2.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

3.  Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes.

Authors:  Hesham Alharby; Talaat Abdelati; Mostafa Rizk; Eman Youssef; Khaled Moghazy; Noha Gaber; Saeed Yafei
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-09-10

4.  Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.

Authors:  Thomas J van 't Erve; Maria B Kadiiska; Stephanie J London; Ronald P Mason
Journal:  Redox Biol       Date:  2017-03-28       Impact factor: 11.799

5.  Metabolic risk factors in mice divergently selected for BMR fed high fat and high carb diets.

Authors:  Julita Sadowska; Andrzej K Gębczyński; Marek Konarzewski
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

6.  Anti-Oxidant and Anti-Endothelial Dysfunctional Properties of Nano-Selenium in vitro and in vivo of Hyperhomocysteinemic Rats.

Authors:  Zeqi Zheng; Lijuan Liu; Kaiwen Zhou; Lu Ding; Junyi Zeng; Wan Zhang
Journal:  Int J Nanomedicine       Date:  2020-06-23

7.  The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension.

Authors:  Michał Biernacki; Marta Baranowska-Kuczko; Gabriella N Niklińska; Elżbieta Skrzydlewska
Journal:  Biomolecules       Date:  2020-07-10

8.  Changes in the blood antioxidant defense of advanced age people.

Authors:  Mariusz Kozakiewicz; Maciej Kornatowski; Olga Krzywińska; Kornelia Kędziora-Kornatowska
Journal:  Clin Interv Aging       Date:  2019-05-01       Impact factor: 3.829

Review 9.  The role of lipid metabolism in aging, lifespan regulation, and age-related disease.

Authors:  Adiv A Johnson; Alexandra Stolzing
Journal:  Aging Cell       Date:  2019-09-27       Impact factor: 9.304

10.  Anxiolytic and anti-stress effects of acute administration of acetyl-L-carnitine in zebrafish.

Authors:  Lais Pancotto; Ricieri Mocelin; Matheus Marcon; Ana P Herrmann; Angelo Piato
Journal:  PeerJ       Date:  2018-07-31       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.